Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study

NCT02401269 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT02401269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02401269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study
Lead sponsor
University of Pittsburgh
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2015
Completion date
January 31, 2016
Enrollment
91 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease risk in hiv patients, endothelial function